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p63 is the molecular switch
for initiation of an epithelial
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Development of stratified epithelia, such as the epider-
mis, requires p63 expression. The p63 gene encodes iso-
forms that contain (TA) or lack (N) a transactivation
domain. We demonstrate that TAp63 isoforms are the
first to be expressed during embryogenesis and are re-
quired for initiation of epithelial stratification. In addi-
tion, TAp63 isoforms inhibit terminal differentiation,
suggesting that TAp63 isoforms must be counterbal-
anced by Np63 isoforms to allow cells to respond to
signals required for maturation of embryonic epidermis.
Our data demonstrate that p63 plays a dual role: initiat-
ing epithelial stratification during development and
maintaining proliferative potential of basal keratino-
cytes in mature epidermis.
Received October 28, 2003; revised version accepted
December 1, 2003.
Development of the epidermis requires a series of coor-
dinated events, which regulate proliferation and differ-
entiation of keratinocytes. Although recent discoveries
have highlighted a number of genes required for terminal
differentiation of keratinocytes (Hu et al. 1999; Takeda
et al 1999; Rangarajan et al. 2001; Nickoloff et al. 2002;
Nicolas et al. 2003), a question that remains is how the
single-layered surface ectoderm commits to initiate
stratification during embryogenesis. A candidate gene
involved in this process is the transcription factor p63.
p63 is expressed in the surface ectoderm prior to strati-
fication and continues to be expressed during embryonic
development. As the epidermis matures, p63 expression
becomes restricted to the basal layer. In adult tissues,
p63 is expressed in stratified epithelia, whereas its ex-
pression is absent from single-layered epithelia (Yang et
al. 1998). These expression data suggest a role for p63 in
the development and maintenance of stratified epithelia,
such as the epidermis. In support of this hypothesis, in-
vestigators found that mice lacking p63 display a funda-
mental defect in epithelial lineage development and fail
to develop stratified epithelia and epithelial appendages,
such as teeth, hair follicles and mammary glands (Mills
et al. 1999; Yang et al. 1999). The surface epithelium of
p63−/− newborn mice consists of a single cell layer that
fails to express epidermal differentiation markers, in-
cluding keratins K5 and K14 (Mills et al. 1999; Yang et al.
1999). The lack of stratification and the consequent ab-
sence of barrier formation in p63−/− mice results in de-
hydration and death within hours after birth. This fun-
damental defect in stratified epithelial lineage develop-
ment displayed by p63−/− mice has led to two hypotheses
concerning the potential role of p63 in epidermal devel-
opment. It has been proposed that p63may play a pivotal
role in maintaining the stem cell population in an al-
ready committed stratified epithelium (Yang et al. 1999;
Pellegrini et al. 2001). Alternatively, p63 may play a
critical role in the commitment to stratified epithelial
lineages (Mills et al. 1999).
In an attempt to distinguish between these hypoth-
eses, we further investigated the molecular role of p63 in
development of the embryonic epidermis and mainte-
nance of the mature epidermis. p63 is expressed in at
least six isoforms (Yang et al. 1998). The use of alterna-
tive promoters and transcription start sites gives rise to
two classes of p63 transcripts: those encoding proteins
with an amino terminal transactivation domain (TA iso-
forms) and those encoding proteins lacking this domain
(N isoforms). In addition, alternative splicing gives rise
to three different carboxyl termini designated , , and .
In vitro data suggest that Np63 isoforms have a domi-
nant-negative function toward TAp63 isoforms (Yang et
al. 1998); however, Np63 isoforms were also shown to
be able to transactivate target gene expression (Dohn et al.
2001; King et al. 2003; Wu et al. 2003), possibly because of
the presence of a second transactivation domain within
Np63 isoforms (Ghioni et al. 2002). It has been reported
that the predominant p63 isoform expressed inmature epi-
dermis is Np63 (Yang et al. 1998; Liefer et al. 2000).
We now demonstrate that TAp63 isoforms are the first
p63 isoforms expressed during embryogenesis and that
they are required for initiation of epithelial stratifica-
tion. Furthermore, ectopic expression of a TAp63 iso-
form in a simple epithelium in vivo resulted in the in-
duction of squamous metaplasia, confirming the role of
p63 as a master molecular switch. We also show that
TAp63 isoforms inhibit terminal differentiation, sug-
gesting that TAp63 isoforms must be counterbalanced
by Np63 isoforms to allow cells to respond to signals
required for maturation of embryonic epidermis. Our
data are consistent with p63 playing a dual role: initiat-
ing epithelial stratification during development and
maintaining proliferative potential of basal keratino-
cytes in mature epidermis.
Results and Discussion
From the expression pattern of p63 and the phenotype of
p63−/− mice, we hypothesized that p63 is required for the
induction of an epithelial stratification program. In sup-
port of this hypothesis, we have isolated p63−/− cells
from the surface epithelium of E18.5 p63−/− mice. Like
p63−/− skin, p63−/− cells failed to express K5 and K14 (Fig.
1), differentiation markers that are expressed in epithelia
that have committed to initiate a stratification program
(Byrne et al. 1994), as well as terminal differentiation
markers K1 and loricrin (data not shown). Instead, p63−/−
[Keywords: p63; stratified epithelia; molecular switch; embryogenesis;
terminal differentiation; proliferative potential]
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cells expressed K18, which is normally synthesized in
the surface ectoderm prior to stratification and in adult
single-layered epithelia (Jackson et al. 1981; Moll et al.
1982). These data demonstrate that without p63, surface
epithelial cells are intrinsically blocked in their commit-
ment to become a keratinocyte.
To study the role of p63 during epidermal morphogen-
esis, we determined the expression profiles of TA- and
Np63 isoforms during embryonic development. We
found that Np63 isoforms were first expressed at E9.5,
after the developing epidermis has committed to strati-
fication, but prior to terminal differentiation (Fig. 2a;
Byrne et al. 1994). However, TAp63 isoforms were de-
tected as early as E7.5, prior to the commitment to strati-
fication. In addition, we observed nuclear p63 staining in
every cell in the surface ectoderm of E8.5 embryos, sug-
gesting that expression of TAp63 isoforms is required in
this tissue (Fig. 2b,c). Based on these data, we hypoth-
esized that TAp63 isoforms may be required for the ini-
tiation of an epithelial stratification program. To test
this hypothesis, we transfected expression constructs en-
coding TAp63, TAp63, Np63, and Np63 into
cells that do not express p63 or K14 (Ptk2 cells, HR9
cells, and F9 cells) and analyzed the induction of K14
expression. As expected from their expression patterns,
we found that only TAp63 isoforms were able to induce
K14 expression, whereas Np63 isoforms did not affect
K14 expression (Fig. 3a). To determine whether TAp63
isoforms could initiate a stratification program in vivo,
we ectopically expressed TAp63 in single-layered lung
epithelia by using “gene-switch” mice (Wang et al. 1997,
1999; Cao et al. 2002). The regulator of the gene-switch
system (Glp65) is activated by progesterone antagonists
such as RU486 and was placed under control of the sur-
factant protein C promoter (SP-C.Glp65), as previously
described (Zhao et al. 2001). The SP-C promoter targets
transgene expression to the cuboidal, surfactant-secret-
ing type II alveolar cells and to the distal Clara cells,
which line the bronchioles of the lung (Wikenheiser and
Whitsell 1997). Neither of these cell types normally ex-
presses p63 (Yang et al. 1998) or markers of stratified
epithelial differentiation, K5 and K14 (Fig. 3e,f; Kasper et
al. 1993). Adult bigenic SP-C.Glp65/TAp63 mice, SP-
C.Glp65/Np63 mice, and control mice were treated
with 500 µg/kg RU486 once daily for 7 d, which resulted
in induction of transgene expression (Fig. 3b). Lung bi-
opsy specimens demonstrated that ectopic TAp63 ex-
pression resulted in the induction of K5 and K14 expres-
sion in type II alveolar cells (data not shown). Further-
more, squamous metaplastic lesions developed in the
bronchioles (Fig. 3d), which expressed K5 and K14 (Fig.
3e; data not shown). Similar results were obtained when
E18.5 lungs were analyzed from embryos in which
TAp63 expression was induced starting at E8.5 by in-
jecting pregnant mice daily with 100 µg/kg RU486 (Fig.
3f; data not shown). In contrast, ectopic expression of
Np63 using the same gene-switch system did not alter
lung morphology and did not result in induction of K5
and K14 (Fig. 3c; data not shown). Taken together, these
data demonstrate that TAp63, but not Np63, can
commit a single-layered epithelium to initiate a stratifi-
cation program.
To further analyze the role of p63, we used the gene-
switch mice to target the overexpression of TAp63 to
the basal layer of the epidermis and hair follicles by us-
ing a K14 promoter (K14.Glp65; Berton et al. 2000; Cao
et al. 2002). Adult (Fig. 4a–c) or newborn (data not
shown) mice were treated topically once daily for 5 d
with 100 µg RU486 to induce TAp63 expression. Skin
biopsy specimens exhibited severe hyperplasia (Fig. 4a),
and BrdU incorporation assays demonstrated that this
hyperplasia was the result of hyperproliferation (Fig. 4b).
In control epidermis, BrdU-labeled cells were detected
sporadically in the basal layer. However, induction of
TAp63 expression resulted in an increase in BrdU-la-
beled cells in the basal layer as well as the presence of
BrdU-labeled cells in the suprabasal layers of the epider-
mis (control 4.6 ± 2.1 cells/mm vs. TAp63-induced
97.2 ± 5.0 cells/mm, P<0.01; Fig. 4b). In addition, induc-
tion of TAp63 expression in the epidermis resulted in
Figure 1. Primary p63−/− surface epithelial cells are blocked in their
commitment to a stratified epithelial lineage. Differentiation mark-
ers K5 and K14, which are expressed in epithelia that have commit-
ted to a stratification program, are not expressed in primary p63−/−
cells. These cells do, however, express K18, a marker for single-
layered epithelia.
Figure 2. Differential expression of p63 isoforms occurs during em-
bryonic development. RT-PCR analysis using primers specific for
TA- or Np63 demonstrated that TAp63 isoforms are expressed as
early as E7.5, whereas Np63 isoforms are not expressed until E9.5
(a). Immunofluorescence (b) and whole-mount immunohistochem-
istry (c) using the mAb4A4 antibody confirmed nuclear localization
of TAp63 isoforms in the surface ectoderm of E8.5 embryos.
p63 initiates epithelial stratification
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perturbed epidermal differentiation as demonstrated by a
delayed onset of K1 expression (Fig. 4c), indicating an
apparent failure of the basal keratinocytes to commit to
terminal differentiation. We also induced TAp63 ex-
pression in developing embryos starting at E8.5. Skin
biopsies taken at E18.5 demonstrated that induction of
TAp63 expression in embryonic epi-
dermis, like that in newborn and
adult epidermis, resulted in severe
hyperplasia (Fig. 4d), hyperprolifera-
tion (data not shown), and a delayed
onset of differentiation (Fig. 4e).
In an attempt to determine if
TAp63 expression could completely
block terminal differentiation, we ini-
tiated RU486 treatment at E3.5 and
analyzed the skin phenotype at E13.5.
At this stage, in control embryos, the
epidermis covering the fore- and hind-
limbs had initiated stratification and
had formed the future spinous layer,
which expressed K1 (Fig. 4f). How-
ever, induction of TAp63 expression
in embryonic epidermis resulted in a
failure to initiate stratification (Fig.
4f). To confirm that TAp63 expres-
sion prevents terminal differentia-
tion, we isolated primary keratino-
cytes from the epidermis of newborn
K14.Glp65/TAp63 mice and control
mice. When primary keratinocytes
are maintained in media with a low
Ca2+ concentration (0.05 mM), they
proliferate and do not undergo termi-
nal differentiation. When the Ca2+
concentration is increased (0.1 mM),
primary keratinocytes differentiate
and initiate expression of K1 (Fig. 4g;
Yuspa et al. 1989). However, when we
induced TAp63 expression in pri-
mary keratinocytes, the cells failed to
differentiate after increasing the Ca2+
concentration and did not initiate K1
expression (Fig. 4h). In addition, it was
recently demonstrated that overexpression of Np63 in
primary mouse keratinocytes prevents Ca2+-induced dif-
ferentiation (King et al. 2003). Taken together, these
findings support an additional role for p63 in maintain-
ing keratinocytes in the proliferative compartment and
in preventing their entry into terminal differentiation.
Figure 3. Ectopic expression of TAp63 initiates a stratification program in vitro and in vivo.
Immunofluorescence on Ptk2 cells transfected with the indicated p63 expression constructs
demonstrated that only TAp63 isoforms could induce K14 expression (∼75% of the transfected
cells; a). To determine if p63 could also induce a stratification program in vivo, we induced
ectopic expression of TAp63 or Np63 in single-layered lung epithelia by using gene-switch
mice. Induction of TAp63 or Np63 transgene expression was determined by RT-PCR (b).
Ectopic expression of Np63 in single-layered lung epithelia did not alter lung morphology
(c). Ectopic expression of TAp63, however, resulted in squamous metaplastic lesions in the
bronchioles (d) and induction of K14 expression, a marker for stratified epithelia, in adult (e)
and E18.5 (f) lungs. TTF1 staining was used to identify type II alveolar cells and distal Clara
cells in the bronchioles.
Figure 4. Induction of TAp63 expression results in hyperplasia, hyperproliferation, and inhibition of terminal differentiation. Induction of
TAp63 expression in adult skin resulted in hyperplasia (a), hyperproliferation as demonstrated by a BrdU incorporation assay (b), and a delayed
onset of terminal differentiation as demonstrated by a delayed onset of K1 expression (c). Induction of TAp63 at E8.5 resulted in hyperplasia
(d) and a delayed onset of K1 expression (e) at E18.5. When TAp63 expression was induced starting at E3.5, at E13.5 the developing epidermis
covering the fore-and hindlimbs demonstrated a lack of K1 expression (f). The ability of TAp63 to block terminal differentiation was further
demonstrated by the failure of primary keratinocytes, in which TAp63 expression was induced, to undergo Ca2+-induced differentiation (g,h).
Koster et al.
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On the basis of our data, we hypothesize that one role
of Np63 during epidermal development is to counter-
balance the effects of TAp63 on terminal differentia-
tion, thereby allowing cells to respond to terminal dif-
ferentiation signals. To test whether this is true in vivo,
we mated the components of the gene-switch system
into the p63+/− background, in which expression levels of
all p63 isoforms are 50% of the levels in wild-type mice.
Because Np63 is the predominant p63 isoform ex-
pressed in the mature epidermis (Yang et al. 1998; Liefer
et al. 2000), this decrease in p63 isoform expression
mostly affects Np63 levels. TAp63 expression was
induced in a p63+/− background in newborn (Fig. 5a–d)
or adult (data not shown) mice. The shift in p63 iso-
form expression results in a situation where TAp63
isoforms are the predominantly expressed isoforms,
thereby mimicking the p63 expression profile during
early epidermal development. After 4 d of daily topical
treatments with 100 µg RU486, newborn K14.Glp65/
TAp63/p63+/− mice appeared dehydrated and their skin
exhibited cracks and peeling (Fig. 5a). Immunofluores-
cence analysis demonstrated that K1 expression was
confined to the outermost layers of the epidermis where
the skin was intact (Fig. 5c), and loricrin expression was
completely absent (Fig. 5d). The lack of loricrin ex-
pression would impair formation of epidermal barrier
function and result in water loss (Koch et al. 2000). In
addition, an examination of adjacent eroded areas re-
vealed that the epidermis was completely missing, sug-
gesting that the marked inhibition of terminal differ-
entiation also resulted in epidermal fragility (Fig. 5b–d).
In essence, this phenotype resembles the immature
embryonic skin at E14.5–E15.5, just prior to epidermal
stratification. In summary, these data demonstrate that
induction of TAp63 in a p63+/− background results in
an increased severity of the inhibition of terminal differ-
entiation. Because in vitro data demonstrated that Np63
has a dominant-negative function toward TAp63 (Yang et
al. 1998), we speculate that the switch in expression of p63
isoforms toward Np63 isoforms during epidermal devel-
opment is required to counterbalance the inhibitory effect
of TAp63 on terminal differentiation.
On the basis of our data, we propose that TAp63 is
the molecular switch that initiates an epithelial stratifi-
cation program. Execution of this program requires a
shift in the balance between the p63 isoforms toward
Np63 isoforms to allow keratinocytes to respond to sig-
nals required for maturation of the epidermis. Once the
mature epidermis is formed, persistently elevated p63
levels in the basal layer of the mature epidermis are re-
quired for maintaining the proliferative potential of ke-
ratinocytes. The proliferative capacity of basal keratino-
cytes may be maintained through inhibition of p21 and
14-3-3 expression via direct binding of Np63 to their
promoters (Westfall et al. 2003). Withdrawal from the
cell cycle and commitment to terminal differentiation
may be partially orchestrated by signaling through
Notch and IKK, two molecules required for terminal
differentiation of the epidermis (Hu et al. 1999; Takeda
et al. 1999; Rangarajan et al. 2001; Nickoloff et al. 2002;
Nicolas et al. 2003).
Materials and methods
Primary keratinocyte culture
p63−/− cells were isolated from the surface epithelium of E18.5 p63−/−
mice. Skins were floated overnight on DispaseII (Roche) at 4°C and pri-
mary keratinocytes were isolated as described previously (Yuspa et al.
1989). Cells were cultured in 50% fibroblast-conditioned medium
supplemented with 0.05 mM Ca2+ and 4 ng/mL epidermal growth factor.
Immunofluorescence was performed 48 h after plating. Cells were sub-
cultured when the cultures reached 90% confluency.
For the in vitro differentiation assays, primary keratinocytes were iso-
lated from the epidermis of newborn K14.Glp65/TAp63 and control
mice (K14.Glp65 and TAp63 monogenic mice) as described previously
(Yuspa et al. 1989). Transgene expression was induced by supplementing
the media with 100 nM RU486. For the differentiation assays, the Ca2+
concentration in the media was increased to 0.1 mM 7 d after plating the
cells, and cells were harvested for immunofluorescence 24 h later.
Cell lines and transfections
Cell lines that do not express p63 and K14 were identified using RT-PCR
and immunofluorescence. Ptk2 cells (rat kangaroo kidney epithelial
cells) were grown in supplemented EMEM medium (Cambrex Bio Sci-
ence). HR9 cells (mouse embryonic endodermal cells) and F9 cells (mouse
embryonic teratocarcinoma cells) were grown in supplemented DMEM
medium (Invitrogen). Cells were transfected with expression constructs
Figure 5. Induction of TAp63 expression in the presence of re-
duced levels of Np63 results in epidermal fragility. TAp63 ex-
pression was induced in the epidermis of K14.Glp65/TAp63 mice
on a p63+/− or p63+/+ genetic background. Although K14.Glp65/
TAp63/p63+/+ mice looked macroscopically normal after 4 d of
RU486 treatment, K14.Glp65/TAp63/p63+/− mice developed fis-
sures in the epidermis (a). Histologically, the lesions in K14.Glp65/
TAp63/p63+/− epidermis appeared eroded (b–d). In the epidermis
adjacent to these lesions, K1 expression was confined to the outer-
most layers of the epidermis (c), and loricrin expression was absent (d),
providing an explanation for the apparent fragility of the epidermis.
p63 initiates epithelial stratification
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encoding myc epitope-tagged TAp63, Np63, TAp63, and Np63
(Yang et al. 1999) using FuGene6 (Roche). Cells were harvested for im-
munofluorescence 48 h posttransfection.
Transgenic/knockout mouse lines
To generate the inducible TAp63/Np63 transgenes, we cloned the
cDNAs encoding mouse TAp63/Np63 into the UAS-TK vector or
UAS-TATA vector, respectively (Wang et al. 1997). Transgenic mice
were generated by standard techniques. Founder mice were identified by
tail tip DNA PCR analysis using primers TK.FW (5-GGTCGAAGCG
GAGTACTGTC-3) and m63–2R (5-GCATCGTTTCACAACCTCG-3).
K14.Glp65, SP-C.Glp65, and p63+/− mice were previously generated and
characterized (Mills et al. 1999; Zhao et al. 2001; Cao et al. 2002).
Administration of RU486 to mice
To induce transgene expression in SP-C.Glp65/TAp63 and SP-C.Glp65/
Np63mice, we injected 500 µg/kg RU486 (Mifepristone; Biomol), dis-
solved in sesame oil, i.p. once daily for 7 d. Adult or newborn K14.Glp65/
TAp63 and control mice were treated topically for 5 d with 100 µg
RU486, dissolved in 70% ethanol. To induce transgene expression in
utero, we injected pregnant mice daily with 100 µg/kg RU486 and 0.5 mg
progesterone (to prevent potential abortion; Sigma), dissolved in sesame
oil. Transgene induction in bigenic mice was confirmed by RT-PCR and
RNase protection assays.
In vivo BrdU incorporation and analysis
Newborn or adult mice were injected i.p. with 250 µg/g BrdU (Sigma) in
0.9% sterile saline solution. Skin biopsies were taken 1 h later and fixed
in 10% neutral buffered formalin (NBF). To determine the proliferative
index, we counted four fields of cells from four independent samples and
calculated the average number of BrdU positive cells per mm skin.
Immunofluorescence and whole-mount immunohistochemistry
Lung tissue was fixed in 10% NBF by gravity perfusion through the
cannulated trachea. Skin biopsies were fixed flat in 10% NBF. Cultured
cells were fixed in cold methanol. Primary antibodies used for immuno-
fluorescence were guinea pig anti-K14 (Yuspa et al. 1989), rabbit anti-K5
(Yuspa et al. 1989), rabbit anti-K6 (Mills et al. 1999), rabbit anti-K1
(Yuspa et al. 1989), rabbit anti-loricrin (Mills et al. 1999), mouse anti-K18
(Sigma), TTF-1 (thyroid transcription factor 1), mAb4A4 (p63; Yang et al.
1999), and FITC-conjugated anti-BrdU (Becton Dickinson). Secondary an-
tibody conjugates used were Alexa-conjugated fluorochromes 594 goat
anti-guinea pig, 488 goat anti-rabbit, 594 goat anti-rabbit, and 488 goat
anti-mouse (Molecular Probes). For whole-mount immunohistochemis-
try, embryos were fixed in 4% paraformaldehyde. Embryos were incu-
bated with the mAb4A4 antibody followed by biotinylated horse anti-
mouse (Vector Laboratories) and ABC Elite reagent (Vector Laboratories).
To detect the substrate, we incubated embryos in DAB/NiCl2 followed
by H2O2.
RT-PCR analysis
To determine the expression profile of p63 isoforms during embryogen-
esis, we obtained timed pregnant ICR mice from Harlan. RNA was ex-
tracted using RNeasy Kits (Qiagen) from whole embryos for stages E7.5
through E9.5 and from epidermis for stages E15.5 through newborn. Re-
verse transcription of 2 µg of RNA was performed using random
hexamers (Promega) and Moloney murine leukaemia virus reverse tran-
scriptase (Promega). TAp63, Np63, and GAPDH expression were de-
tected by RT-PCR using primers m63TA.F (5-TCGCAGAGCAC
CCAGACA-3) and m63–2R for TAp63; m63N.F (5-TTGTACCTG
GAAAACAATG-3) and m63–2R for Np63; and GAPDH1 (5-AAGGT
CGGTGTGAACGGATT-3) and GAPDH2 (5-TGGTGGTGCAGGAT
GCATTG-3) for GAPDH. To confirm transgene induction in gene-
switch mice, we detected TAp63 and Np63 transgenes by RT-PCR
using primers TK.FW and m63–2R.
All experiments involving mice were performed under IACUC ap-
proval (Protocol number: AN-546).
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